OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Enfortumab vedotin–related cutaneous toxicity correlates with overall survival in patients with urothelial cancer: a retrospective experience
Evangelia Vlachou, Burles A. Johnson, David J. McConkey, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 7
Evangelia Vlachou, Burles A. Johnson, David J. McConkey, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 7
Showing 7 citing articles:
Nectin‐4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical Study
Ezra Baraban, Evangelia Vlachou, Sunil Patel, et al.
The Prostate (2025)
Closed Access | Times Cited: 1
Ezra Baraban, Evangelia Vlachou, Sunil Patel, et al.
The Prostate (2025)
Closed Access | Times Cited: 1
Influence of best objective response to first‐line treatment on survival outcomes in advanced urothelial carcinoma in the era of sequential therapy with enfortumab vedotin
Kohei Kobatake, Keisuke Goto, Yuki Sakamoto, et al.
International Journal of Urology (2025)
Open Access | Times Cited: 1
Kohei Kobatake, Keisuke Goto, Yuki Sakamoto, et al.
International Journal of Urology (2025)
Open Access | Times Cited: 1
Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real‐World Multicenter Study
Kai Ozaki, Hayato Yamamoto, Yuya Sekine, et al.
International Journal of Urology (2025)
Open Access
Kai Ozaki, Hayato Yamamoto, Yuya Sekine, et al.
International Journal of Urology (2025)
Open Access
Enfortumab vedotin for metastatic urothelial carcinoma: Comprehensive treatment outcomes and prognostic insights from a multicenter real-world study (YUSHIMA study)
Y. Nakamura, Hajime Tanaka, Noboru Numao, et al.
Clinical Genitourinary Cancer (2025), pp. 102301-102301
Closed Access
Y. Nakamura, Hajime Tanaka, Noboru Numao, et al.
Clinical Genitourinary Cancer (2025), pp. 102301-102301
Closed Access
A case of pagetoid spread of urothelial carcinoma with notable reduction achieved through enfortumab vedotin, resulting in complete surgical resection
K. Tokuoka, Katsuki Muramoto, Keigo Sakanaka, et al.
International Cancer Conference Journal (2024) Vol. 13, Iss. 4, pp. 510-514
Closed Access
K. Tokuoka, Katsuki Muramoto, Keigo Sakanaka, et al.
International Cancer Conference Journal (2024) Vol. 13, Iss. 4, pp. 510-514
Closed Access
Incidence, risk factors, and clinical implications of enfortumab vedotin-related cutaneous toxicity in urothelial carcinoma: a large-scale, real-world study in Japan
Yuki Kita, Takuto Hara, Takashi Kawahara, et al.
ESMO Real World Data and Digital Oncology (2024) Vol. 7, pp. 100094-100094
Closed Access
Yuki Kita, Takuto Hara, Takashi Kawahara, et al.
ESMO Real World Data and Digital Oncology (2024) Vol. 7, pp. 100094-100094
Closed Access
